
life span lymphoma-incidence mice injected birth spleen 
cells across weak histocompatibility locus . 
  newborn cogenic c h mice receiving injections across weak (h-i h-i ) 
histocompatibility barrier exhibited life-shortening high 
incidence lymphomatous disease mid-adult life . control 
experiments (h-i h-i ) lymphomatous disease developed much later life . 
mouse strains given injections new-borns manifest 
negligible incidence lymphoma leukemia . findings 
variably interpretable terms oncogenic virology, 
immunologic theories aging cancer analogy transplantation 
disease mechanisms . 
